{
  "docId": "019dd923-5f69-752d-a9bb-90c202bf2c94",
  "docSlug": "lcqgfQ7imBXz1NbaQgtT",
  "documentTitle": "Here's the pitch deck that AI-backed drug discovery startup Atomwise used to raise $123 million in Series B funding",
  "authorId": "Pitchdecks",
  "authorName": "Atomwise",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.777,
  "pageNumber": 12,
  "pageCount": 14,
  "prevPage": 11,
  "nextPage": 13,
  "slideType": "testimonial",
  "function": "illustrate_case",
  "density": "overcrowded",
  "nDataPoints": 0,
  "notes": "The slide features a 3D protein structure visualization alongside a quote from a scientific co-founder.",
  "elementsJson": [
    "headline_text",
    "subtitle_text",
    "quote_block",
    "headshot",
    "photo"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5f69-752d-a9bb-90c202bf2c94/12",
  "deckHref": "/decks/019dd923-5f69-752d-a9bb-90c202bf2c94",
  "deckJsonHref": "/decks/019dd923-5f69-752d-a9bb-90c202bf2c94.json",
  "deckAnchorHref": "/decks/019dd923-5f69-752d-a9bb-90c202bf2c94#slide-12",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Theia Biosciences is focused initially on meeting an unmet medical need in helping treat age-related macular degeneration through developing small molecule inhibitors.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd952-d520-7729-8314-156f931e11d9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.15,
        "x": 0.1,
        "y": 0.65
      },
      "kind": "image",
      "text": "Dr. Jeff Perry",
      "attrs": null,
      "subkind": "headshot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "114c79ad-59e7-4017-a013-8becdc064ac1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.7,
        "w": 0.35,
        "x": 0.6,
        "y": 0.1
      },
      "kind": "image",
      "text": "3D protein structure",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "805fa490-6ab4-4ef5-b0e8-6db3ea15b1aa",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.2,
        "x": 0.26,
        "y": 0.65
      },
      "kind": "paragraph",
      "text": "Dr. Jeff Perry\nAssistant Professor of\nBiochemistry at UC Riverside\nand Scientific Co-founder of\nTheia Biosciences",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e6a0afd6-e91a-47a6-8a78-7936bd9eb398",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.5,
        "x": 0.04,
        "y": 0.25
      },
      "kind": "quote",
      "text": "Theia Biosciences is building off of the initial research started in collaboration with Atomwise during my first AIMS Award. Theia Biosciences is focused initially on meeting an unmet medical need in helping treat age-related macular degeneration through developing small molecule inhibitors.",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c9ec0eaa-df5e-4400-a8e5-8f7b0cb2ef45",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "Theia Biosciences is building off of the initial research started in collaboration with Atomwise during my first AIMS Award. Theia Biosciences is focused initially on meeting an unmet medical need in helping treat age-related macular degeneration through developing small molecule inhibitors. — Dr. Jeff Perry, Assistant Professor of Biochemistry at UC Riverside and Scientific Co-founder of Theia Biosciences",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd952-d520-7729-8314-1ab6204a0713",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.5,
        "x": 0.04,
        "y": 0.05
      },
      "kind": "title",
      "text": "From Gene Variant to Potential Cure",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2ac6d738-2a50-46a9-bf9b-1bd768c6c4b1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.04,
        "y": 0.13
      },
      "kind": "title",
      "text": "HTRA1 - 1st in class treatment for Age-Related Macular Degeneration (AMD)",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a858671b-d0cc-4f7a-9a7a-fc31c16e1fd6",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}